EndoShape is looking to raise $2.5 million in a new round of debt financing, according to a new SEC filing from the coil embolization and occlusion company.
The Boulder, Colo.-based device maker develops minimally invasive plugs and coils for occluding blood vessels, including its flagship Medusa MultiCoil, which has FDA 510(k) clearance. The device is indicated for arterial and venous embolization in the peripheral vasculature.
Endoshape has already raised $1.2 million with $1.3 million left before it closes the round. The company did not disclose the identities of the 11 investors involved in the round, but lists High Country Venture and Volcano Capital as investors on its website.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.